These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 33464184)

  • 21. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of biomarkers and imaging in the clinical diagnosis of dementia.
    Bayer AJ
    Age Ageing; 2018 Sep; 47(5):641-643. PubMed ID: 29432519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET Agents in Dementia: An Overview.
    van Waarde A; Marcolini S; de Deyn PP; Dierckx RAJO
    Semin Nucl Med; 2021 May; 51(3):196-229. PubMed ID: 33500121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current and future prospects of nuclear medicine in dementia].
    Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
    Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain imaging in Alzheimer disease.
    Johnson KA; Fox NC; Sperling RA; Klunk WE
    Cold Spring Harb Perspect Med; 2012 Apr; 2(4):a006213. PubMed ID: 22474610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease.
    Heiss WD
    J Nucl Med; 2018 Nov; 59(11):1660-1664. PubMed ID: 29959217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].
    Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular imaging of Alzheimer disease pathology.
    Kantarci K
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S12-7. PubMed ID: 24503555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
    Bevan-Jones WR; Surendranathan A; Passamonti L; Vázquez Rodríguez P; Arnold R; Mak E; Su L; Coles JP; Fryer TD; Hong YT; Williams G; Aigbirhio F; Rowe JB; O'Brien JT
    BMJ Open; 2017 Jan; 7(1):e013187. PubMed ID: 28064175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: a systematic review.
    Davison CM; O'Brien JT
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):551-61. PubMed ID: 24123413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.
    Kollack-Walker S; Liu CY; Fleisher AS
    Neurol Clin; 2017 May; 35(2):231-262. PubMed ID: 28410658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT).
    Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA
    Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing dementia.
    Wang DC; Black SE; Zukotynski KA
    CMAJ; 2016 May; 188(8):603. PubMed ID: 27067820
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroimaging in Dementias.
    Mahalingam S; Chen MK
    Semin Neurol; 2019 Apr; 39(2):188-199. PubMed ID: 30925612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.
    Nasrallah IM; Wolk DA
    J Nucl Med; 2014 Dec; 55(12):2003-11. PubMed ID: 25413136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease.
    Ossenkoppele R; Hansson O
    Alzheimers Dement; 2021 Dec; 17(12):1998-2008. PubMed ID: 33984177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SPECT imaging in dementia.
    Pimlott SL; Ebmeier KP
    Br J Radiol; 2007 Dec; 80 Spec No 2():S153-9. PubMed ID: 18445745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the diagnostic sensitivity of MRI, CBF-SPECT, FDG-PET and cerebrospinal fluid biomarkers for detecting Alzheimer's disease in a memory clinic.
    Morinaga A; Ono K; Ikeda T; Ikeda Y; Shima K; Noguchi-Shinohara M; Samuraki M; Yanase D; Yoshita M; Iwasa K; Mastunari I; Yamada M
    Dement Geriatr Cogn Disord; 2010; 30(4):285-92. PubMed ID: 20861634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.